Clinical Laboratory & Biomarker Core
临床实验室
基本信息
- 批准号:10458362
- 负责人:
- 金额:$ 56.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-02 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAcquired Immunodeficiency SyndromeAreaAwarenessBiologicalBiological AssayBiological MarkersBiological Specimen BanksBiological TestingCatalogingClinicClinicalClinical DataClinical ResearchCollaborationsConsultConsultationsDataData AnalysesDevelopmentEducational process of instructingEquipment and supply inventoriesFacultyFreezingGoalsGuidelinesHIVHIV InfectionsImmunologyInstitutionInternationalInternetInvestigationKnowledgeLaboratoriesMaintenanceMeasuresMentorsMethodsNatural HistoryOutcome StudyPathogenesisPerformancePharmacologyPractice ManagementPreventionPublicationsQuality ControlReadinessResearchResearch PersonnelResourcesSamplingScienceScientistService provisionServicesSpecimenStudentsTestingTissue BanksTrainingbasebiobankdata integritydata managementdesignimprovedinnovationmetabolomicsnext generationprogramsquality assurancerepositorysearchable databaseservice providersvirologyworking group
项目摘要
The overall goals of the JHUCFAR Laboratory core are to provide JHU HIV researchers, especially those
new to HIV, with: a) world‐class laboratory expertise to assist in the optimal design of clinical studies
where specialized laboratory assays are essential to measuring study outcomes, b) access to
appropriate, validated and, where applicable, certified laboratory assays, c) biomarker specimen
repository for the storage, cataloguing and testing of biological specimens, including access to the
clinical data associated with those specimens, and d) training to match the needs of investigators
ranging from understanding how to collaborate with laboratory investigators, incorporate laboratory
tests in a clinical study, judge assay quality and readiness for use to actual performance of the assays in
one’s own laboratory. The Core will establish mechanisms to enhance research in HIV prevention,
treatment, and pathogenesis carried out by both new and established investigators at JHU through
improved awareness of and access to the extensive laboratory resources within the institution and by
establishing connections outside Johns Hopkins when needed. To this end, the Core will directly provide
expert consultation and assay service focused in 4 major scientific areas—virology, immunology,
pharmacology, and metabolomics—as well as providing access to both data and biological specimen
repositories to advance science. Beyond these laboratories, the Core will establish best data
management practices – from clinic to lab to data analysis – and facilitate connections and
collaborations with a far broader array of core laboratories within JHU and in other CFARs nationally.
Jhucfar实验室核心的总体目标是为JHU HIV研究人员提供,尤其是那些
艾滋病毒的新手,a)世界阶级实验室专业知识,以帮助临床研究的最佳设计
如果专门实验室测定对于测量研究结果至关重要,则b)访问
适用,经过验证,并在适用的情况下进行认证的实验室测定,c)生物标记标本
存储,生物标本的存储,编目和测试的存储库,包括访问
与这些标本相关的临床数据以及d)培训以满足研究人员的需求
从了解如何与实验室调查人员合作的范围内,成立了实验室
在一项临床研究,法官测定质量和准备使用测定的实际性能中的测试中的测试
自己的实验室。核心将建立增强艾滋病毒预防研究的机制,
治疗以及新的和已成熟的研究人员在JHU进行的发病机理
提高了对机构内部广泛的实验室资源的认识和获取
在需要时建立约翰·霍普金斯之外的连接。为此,核心将直接提供
专家咨询和分析服务集中在4个主要科学领域 - 媒毒,免疫学,
药理学和代谢组学 - 以及提供数据和生物标本的访问
存储库来推进科学。除了这些实验室之外,核心还将建立最佳数据
管理实践 - 从诊所到实验室再到数据分析 - 并促进联系
与JHU内部和全国其他CFARS内的核心实验室的合作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Craig Walter Hendrix其他文献
Craig Walter Hendrix的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Craig Walter Hendrix', 18)}}的其他基金
Population Pharmacokinetic Modeling and Clinical Trial Simulation to optimize HIV Prevention in Pregnancy and Postpartum
群体药代动力学模型和临床试验模拟可优化妊娠期和产后的艾滋病毒预防
- 批准号:
10316144 - 财政年份:2021
- 资助金额:
$ 56.07万 - 项目类别:
Development of Rectal Enema As Microbicide (DREAM)
直肠灌肠剂作为杀菌剂的开发(DREAM)
- 批准号:
9088326 - 财政年份:2014
- 资助金额:
$ 56.07万 - 项目类别:
Exploratory Pharmcokinetics of UC781 & Tenofovir Vaginal Microbicide Gel V Film
UC781 的探索性药代动力学
- 批准号:
8660270 - 财政年份:2014
- 资助金额:
$ 56.07万 - 项目类别:
Clinical optimization of a tenofovir enema and adherence tracking
替诺福韦灌肠和依从性跟踪的临床优化
- 批准号:
8768695 - 财政年份:2014
- 资助金额:
$ 56.07万 - 项目类别:
Exploratory Pharmcokinetics of UC781 & Tenofovir Vaginal Microbicide Gel V Film
UC781 的探索性药代动力学
- 批准号:
8471644 - 财政年份:2013
- 资助金额:
$ 56.07万 - 项目类别:
The effect of Depo-Provera on HIV susceptibility, immune activation, and PrEP PK
Depo-Provera 对 HIV 易感性、免疫激活和 PrEP PK 的影响
- 批准号:
8588047 - 财政年份:2013
- 资助金额:
$ 56.07万 - 项目类别:
相似海外基金
KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH
KEMRI-PHRD UG1 级联网络单元:艾滋病毒感染女性的宫颈癌预防研究
- 批准号:
10763054 - 财政年份:2023
- 资助金额:
$ 56.07万 - 项目类别:
IAS 2023, the 12th IAS Conference on HIV Science, Brisbane, Australia, and virtually, 23-26 July 2023
IAS 2023,第 12 届 IAS HIV 科学会议,澳大利亚布里斯班,虚拟会议,2023 年 7 月 23-26 日
- 批准号:
10696505 - 财政年份:2023
- 资助金额:
$ 56.07万 - 项目类别:
Hermanos de Luna y Sol: A community-based HIV prevention intervention
Hermanos de Luna y Sol:基于社区的艾滋病毒预防干预措施
- 批准号:
10626689 - 财政年份:2023
- 资助金额:
$ 56.07万 - 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core - Methods
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686544 - 财政年份:2023
- 资助金额:
$ 56.07万 - 项目类别: